TabletCardiovascular
Bosentan · Endothelin receptor antagonist
Bosentan is classed as a endothelin receptor antagonist and is supplied as tablets. Its standard indications include pulmonary arterial hypertension, and it is offered for pharmaceutical supply and export.
Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.
01Specification
02Related